本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Neurosense Therapeutics Ltd

1.93
-0.0020-0.10%
盘前2.090.1800+9.42%04:37 EDT
成交量:50.60万
成交额:95.57万
市值:4,625.02万
市盈率:-3.51
高:1.95
开:1.94
低:1.83
收:1.93
数据加载中...
2025/04/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC问询函

Form CORRESP - Correspondence
2025/01/06

SEC问询函

Form CORRESP - Correspondence
2024/12/13

SEC问询函

Form CORRESP - Correspondence
2024/12/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC问询函

Form CORRESP - Correspondence
2024/11/19

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC问询函

Form CORRESP - Correspondence
2024/05/20

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC问询函

Form CORRESP - Correspondence
2023/09/01

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC问询函

Form CORRESP - Correspondence
2023/08/15

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/14

SEC问询函

Form CORRESP - Correspondence
2023/07/21

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/04/05

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals